Search clinical trials for: Androgen insensitive prostate cancer
Total 88773 results
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingStage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostatic Adenocarcinoma | Castration Levels of TestosteroneUnited States, Switzerland, Mexico, Chile, Colombia
-
The Methodist Hospital Research InstituteRecruitingProstate Cancer | High-risk Prostate CancerUnited States
-
St Vincent's Hospital, SydneyRecruitingCastration-resistant Prostate Cancer | Homologous Recombination DeficiencyAustralia
-
Wake Forest University Health SciencesRecruitingRecurrent Prostate CancerUnited States
-
Yale UniversityNational Cancer Institute (NCI)RecruitingStage IV Prostate Adenocarcinoma AJCC v7United States, Taiwan, Korea, Republic of, Australia, China, Japan
-
Sun Yat-sen UniversityRecruitingProstate Cancer MetastaticChina
-
McMaster UniversityCanadian Cancer Society (CCS); Prostate Cancer CanadaRecruitingCardiovascular Disease | Prostate CancerUnited States, Canada, Australia, Brazil, Israel, Turkey, Colombia
-
Northwestern UniversityRecruitingMetastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Refractory Prostate Cancer | Castration-Resistant Prostatic CancerUnited States
-
University of MiamiBankhead-Coley Florida Biomedical Research ProgramRecruitingProstate CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)RecruitingStage II Prostate Adenocarcinoma | Stage III Prostate AdenocarcinomaUnited States
-
Sir Mortimer B. Davis - Jewish General HospitalRecruitingProstate CancerCanada
-
Olof AkreRecruitingProstatic NeoplasmsDenmark, Norway, Finland, Sweden
-
Advocate Health CareRecruitingProstate AdenocarcinomaUnited States
-
Proton Collaborative GroupRecruitingProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingProstate CancerUnited States
-
BayerOrion Corporation, Orion PharmaActive, not recruitingDarolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer (ARANOTE)Prostatic NeoplasmsChina, Russian Federation, Taiwan, Latvia, India, Australia, Brazil, Canada, Chile, Lithuania, New Zealand, Peru, South Africa, Spain, Ukraine
-
National Cancer Institute (NCI)Completed
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Hormone-Sensitive Prostate CancerChina
-
University of California, San FranciscoMyovant Sciences GmbHCompletedLeveraging Technology to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation TherapyProstate CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Patrick C. Walsh FundActive, not recruitingProstate CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Active, not recruiting
-
National Cancer Institute (NCI)Active, not recruitingCastrate Sensitive Prostate CancerUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Hormone-Sensitive Prostate CancerTaiwan, Poland, United States, Australia, Austria, Brazil, Canada, Chile, China, Colombia, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Peru, Russian Federation, Spai... and more
-
Emory UniversityNational Cancer Institute (NCI)Active, not recruitingBiochemically Recurrent Prostate Carcinoma | Localized Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC... and other conditionsUnited States
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingProstatic Neoplasms, Castration-Resistant | Prostatic Cancer, Castration-Resistant | Castration Resistant Prostatic Neoplasms | Androgen-Resistant Prostatic NeoplasmsUnited States, Canada
-
BayerActive, not recruitingMetastatic Hormone-sensitive Prostate CancerUnited States
-
The Netherlands Cancer InstituteTerminatedProstatic NeoplasmsNetherlands
-
University of Wisconsin, MadisonMerck Sharp & Dohme LLC; Prostate Cancer Foundation; Madison Vaccines, IncActive, not recruitingProstate Cancer | Metastatic Cancer | Castration-resistant Prostate CancerUnited States
-
Novartis PharmaceuticalsActive, not recruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)China
-
Eli Lilly and CompanyActive, not recruitingUrogenital Neoplasms | Prostatic Neoplasms | Neoplasm Metastasis | Enzyme Inhibitors | Antineoplastic Agents | Hormones | Physiological Effects of Drugs | Antineoplastic Agents, Hormonal | Androgens | Hormones, Hormone Substitutes, and Hormone Antagonists | Abiraterone Acetate | Steroid Synthesis Inhibitors | Cytochrome... and other conditionsChina, Canada, France, United States, Australia, Czechia, Hungary, Spain, Germany, Japan, Taiwan, Netherlands, Turkey, Mexico, Belgium, Korea, Republic of, Argentina, Romania, United Kingdom, Italy, Israel, Brazil, Poland, Greece
-
BayerActive, not recruiting
-
Aragon Pharmaceuticals, Inc.Active, not recruitingProstatic NeoplasmsUnited States, France, Poland, Taiwan, Ukraine, United Kingdom, China, Belgium, Germany, Spain, Israel, Mexico, Malaysia, Romania, Turkey, Canada, Netherlands, Korea, Republic of, Brazil, Russian Federation, Argentina, Sweden, Czechia
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; Stand Up To Cancer; High Impact Clinical Research Support...Completed
-
Aragon Pharmaceuticals, Inc.Active, not recruitingProstate CancerUnited States, France, Poland, Ukraine, United Kingdom, China, Spain, Argentina, Israel, Mexico, Romania, Turkey, Korea, Republic of, Japan, Sweden, Canada, Russian Federation, Brazil, Germany, Hungary, Czechia, Australia
-
University of ChicagoActive, not recruitingProstate CancerUnited States
-
Janssen Pharmaceutical K.K.Active, not recruiting
-
Janssen Research & Development, LLCActive, not recruiting
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingMetastatic Hormone Sensitive Prostate CancerKorea, Republic of, Japan, United States, Argentina, Australia, Belgium, Canada, Chile, Denmark, Finland, France, Germany, Israel, Italy, Netherlands, New Zealand, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, United...
-
Janssen Research & Development, LLCActive, not recruiting
-
Janssen Research & Development, LLCActive, not recruitingProstatic NeoplasmsUnited States, Italy, Czechia, Israel, Japan, Taiwan, Korea, Republic of, United Kingdom, France, Spain, Germany, Australia, Canada, Brazil, Netherlands, Russian Federation, Argentina, Poland
-
Sumitomo Pharma Switzerland GmbHActive, not recruitingMetastatic Castration-Resistant Prostate Cancer | Metastatic Castration-Sensitive Prostate Cancer | Non-Metastatic Castration-Resistant Prostate CancerUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingProstate Adenocarcinoma | Recurrent Prostate CarcinomaUnited States
-
University of ChicagoJanssen, LPSuspendedProstate CancerUnited States
-
Astellas Pharma IncActive, not recruitingProgressive Metastatic Prostate CancerChina, Hong Kong, Korea, Republic of, Taiwan
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Prostate Carcinoma | Stage IIA Prostate Cancer AJCC v7 | Stage III Prostate Cancer AJCC v7 | Stage I Prostate Cancer AJCC v7 | Stage IIB Prostate Cancer AJCC v7United States, Ireland
-
University of Kansas Medical CenterOncology Nursing SocietyCompletedFatigue | Cognitive Impairment | Sleep Disturbance | Prostate CancerUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Small Cell Neuroendocrine Carcinoma | Metastatic Prostate Adenocarcinoma | Castration-Resistant...United States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingProstate CancerUnited States
-
Andrew McDonaldNational Cancer Institute (NCI)Active, not recruitingProstate AdenocarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingProstate Cancer | Neoplasms of Prostate | Cancer Of Prostate | Prostate Neoplasms | Prostatic CancerUnited States